De Clerck F - Search Results

1

Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.

Weber C, Beetens JR, Tegtmeier F, Van Rooy P, Vercammen E, Wouters L, De Clerck F. Weber C, et al. Among authors: de clerck f. Thromb Haemost. 1992 Aug 3;68(2):214-20. Thromb Haemost. 1992. PMID: 1412169

2

5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.

De Clerck F, Loots W, Somers Y, Beetens J, Wouters L, Wynants J, Janssen PA. De Clerck F, et al. Br J Pharmacol. 1990 Apr;99(4):631-6. doi: 10.1111/j.1476-5381.1990.tb12982.x. Br J Pharmacol. 1990. PMID: 2113823 Free PMC article.

3

Arachidonic acid metabolites, ADP and thrombin modulate occlusive thrombus formation over extensive arterial injury in the rat.

De Clerck F, Van Gorp L, Beetens J, Verheyen A, Janssen PA. De Clerck F, et al. Blood Coagul Fibrinolysis. 1990 Aug;1(3):247-58. doi: 10.1097/00001721-199008000-00001. Blood Coagul Fibrinolysis. 1990. PMID: 2151728

4

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.

De Clerck F, Beetens J, Van de Water A, Vercammen E, Janssen PA. De Clerck F, et al. Thromb Haemost. 1989 Feb 28;61(1):43-9. Thromb Haemost. 1989. PMID: 2526385

5

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.

De Clerck F, Beetens J, de Chaffoy de Courcelles D, Vercammen E, Freyne E, Janssen PA. De Clerck F, et al. Among authors: de chaffoy de courcelles d. Prog Clin Biol Res. 1989;301:567-72. Prog Clin Biol Res. 1989. PMID: 2529556 No abstract available.

6

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.

De Clerck F, Beetens J, de Chaffoy de Courcelles D, Freyne E, Janssen PA. De Clerck F, et al. Among authors: de chaffoy de courcelles d. Thromb Haemost. 1989 Feb 28;61(1):35-42. Thromb Haemost. 1989. PMID: 2546278

7

Production of thromboxane and prostaglandins in human blood in the presence of thromboxane synthase inhibitors: a comparison of RIA and GC/MS determinations.

Weber C, Beetens JR, Van de Wiele R, Höller M, De Clerck F. Weber C, et al. Among authors: de clerck f. Blood Coagul Fibrinolysis. 1991 Feb;2(1):7-15. doi: 10.1097/00001721-199102000-00002. Blood Coagul Fibrinolysis. 1991. PMID: 1773000

8

Interplay between platelet-derived 5-hydroxytryptamine and arachidonic acid metabolites limits the thrombolytic efficacy of streptokinase against canine platelet-rich coronary thrombosis.

Vandeplassche G, Hermans C, Van Dael L, Wouters L, De Clerck F. Vandeplassche G, et al. Among authors: de clerck f. J Cardiovasc Pharmacol. 1993 Jan;21(1):56-69. doi: 10.1097/00005344-199301000-00009. J Cardiovasc Pharmacol. 1993. PMID: 7678680

9

The effect of a combined administration of ridogrel and ketanserin in patients with intermittent claudication.

De Cree J, Geukens H, Gutwirth P, De Clerck F, Vercammen E, Verhaegen H. De Cree J, et al. Among authors: de clerck f. Int Angiol. 1993 Mar;12(1):59-68. Int Angiol. 1993. PMID: 8376914 Clinical Trial.

10

Gas chromatographic-mass spectrometric determination of 11-dehydrothromboxane B2 in human urine.

Weber C, Beetens J, De Clerck F, Tegtmeier F. Weber C, et al. Among authors: de clerck f. J Chromatogr. 1992 May 20;577(1):1-7. doi: 10.1016/0378-4347(92)80592-e. J Chromatogr. 1992. PMID: 1400727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters